Rapid Development of a Registry to Accelerate COVID-19 Vaccine Clinical Trials.

ABSTRACT:

Background

The unprecedented scientific response to the SARS-Cov-2 pandemic in 2020 required the rapid development and activation of extensive clinical trial networks to study vaccines and therapeutics. The COVID-19 Prevention Network (CoVPN) coordinated hundreds of sites conducting phase 2 and 3 clinical trials of vaccines and antibody therapeutics. To facilitate these clinical trials, the CoVPN Volunteer Screening Registry (VSR) was created to collect volunteer information at scale, identify volunteers at risk of COVID-19 who met enrollment criteria, distribute candidates across clinical trial sites, and enable monitoring of volunteering and enrollment progress.

Methods

We developed a secure database to support three primary web-based interfaces: a national volunteer quest

SUBMITTER: Abernethy NF 

PROVIDER: S-EPMC11213164 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature